EUCTR2009-014469-19-FI进行中（未招募）1 期
Evaluation of Mirtazapine and Folic Acid for Schizophrenia:A Large Simple 2x2 Factorial Trial.
Oxford University0 个研究点目标入组 53 人开始时间: 2011年2月28日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 53
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •diagnosis of DSM-IV schizophrenia
- •? active psychotic symptoms – i.e. hallucinations, delusions, thought disorder
- •? not meeting criteria for current manic episode including schizoaffective disorder
- •? inpatient or outpatient
- •? aged 16 to 70 years.
- •? able and willing to consent to participate
- •? currently taking effective dose of antipsychotic (see Appendix 1 for dose ranges)
- •? no antidepressant treatment within last two weeks and not considering treatment for depression
- •? not taking clozapine
- •? clinically appropriate to change or augment treatment*
- •? adjunctive mirtazapine appears reasonable and both investigator and patient are uncertain whether it will offer any benefit
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- contraindication to investigational medicinal products
- •- pregnancy, breast-feeding or planning a pregnancy
研究者
相似试验
进行中（未招募）
1 期
OCTUMI-4: Evaluation of Mirtazapine and Folic Acid for Schizophrenia: A randomised, double-blind, 2x2 factorial trial - OCTUMI-4MedDRA version: 14.1 Level: PT Classification code 10039626 Term: Schizophrenia System Organ Class: 10037175 - Psychiatric disordersSchizophreniaEUCTR2009-014469-19-GBniversity of Oxford53
已完成
不适用
OCTUMI-4: Evaluation of Mirtazapine and Folic Acid for SchizophreniaMental and Behavioural DisordersSchizophreniaISRCTN32434568niversity of Oxford (UK)334
已完成
4 期
Mirtazapine add-on therapy in the treatment of schizophrenia with atypical neuroleptics: A double-blind, randomised, placebo controlled trialMental Health - SchizophreniaSchizophreniaACTRN12605000577617niversity of Melbourne40
已完成
不适用
Efficacy of add-on mirtazapine on clinical and neuropsychologic parameters in schizophrenic patients treated with conventional antipsychotics: a double-blind, placebo-controlled trial with an open-label extension phaseSchizophreniaISRCTN00721331Stanley Medical Research Institute (USA)40
尚未招募
Unknown
A comparative clinical experiment of mirtazapine and amitriptyline in India on patients with recurring symptoms of an upset stomach that have no obvious causeCTRI/2024/01/061596Indian Council of Medical Research (ICMR)